| # | % | |||||
|---|---|---|---|---|---|---|
| 1101 | HEALTHCARE TR AMER INC | 2,882,099 | 69,027,000 | 0.98% | ||
| 1102 | BROOKDALE SR LIVING INC | 2,478,978 | 86,021,000 | 1.22% | ||
| 1103 | MOMENTA PHARMACEUTICALS INC | 4,141,100 | 94,458,000 | 1.34% | ||
| 1104 | NEUROCRINE BIOSCIE COM USD0.001 | 2,007,183 | 95,864,000 | 1.36% | ||
| 1105 | Axovant Sciences LTD | 5,080,000 | 103,528,000 | 1.47% | ||
| 1106 | ZIMMER BIOMET HLDGS INC | 1,002,458 | 109,498,000 | 1.55% | ||
| 1107 | CONMED CORP | 2,340,000 | 136,352,000 | 1.93% | ||
| 1108 | AETNA INC NEW | 1,230,267 | 156,810,000 | 2.22% | ||
| 1109 | VALEANT PHARMACEUTICALS INTL | 831,417 | 184,699,000 | 2.62% | ||
| 1110 | ENDO INTL PLC | 3,710,724 | 295,560,000 | 4.19% | ||
| 1111 | PERRIGO CO PLC | 2,091,441 | 386,561,000 | 5.48% | ||
| 1112 | LABORATORY CORP AMER HLDGS | 3,373,624 | 408,951,000 | 5.80% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0000950123-15-009536, filed 2015.08.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
